⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRSP News
CRISPR Therapeutics AG
The Inner Circle acknowledges Ilene Fennoy, MD, MPH as a Pinnacle Professional Member Inner Circle of Excellence
prnewswire.com
COLB
SNY
BMY
PFE
MRK
JNJ
ABBV
GILD
AMGN
REGN
BIIB
CRSP
VRTX
MDLZ
KHC
PEP
KO
SBUX
MCD
YUM
CMG
TSLA
NVDA
GOOG
MSFT
AMZN
META
IBM
ORCL
CSCO
ADBE
CRM
INTC
AMD
QCOM
MU
SMCI
ACN
NOW
PANW
SNPS
CDNS
MRVL
LRCX
KLAC
ASML
AMAT
NXPI
ON
INFY
WMT
COST
HD
LOW
TGT
BBY
MGM
LVS
WYNN
MAR
HPE
HPQ
DELL
XRX
GE
BA
LMT
RTX
GD
NOC
CAT
DE
HON
MMM
AXP
V
MA
JPM
BAC
WFC
GS
MS
DIS
CMCSA
NFLX
T
VZ
CHTR
TMUS
XOM
CVX
SHEL
BABA
JD
PDD
NTES
BIDU
IQ
BILI
EDU
RLX
LI
XPEV
NIO
CPT
M
KSS
ROST
TJX
URBN
PVH
RL
AEO
ANF
LULU
UA
NKE
CROX
EAT
SJM
GIS
ADM
IFF
CPB
KDP
MNST
STZ
CCEP
BUD
MOLN
CRBU
EDIT
NTLA
BEAM
ALNY
AZN
BNTX
MRNA
XBIT
RBLX
EXAS
CRWD
FTNT
OKTA
DDOG
SNOW
PLTR
AI
UPST
PYPL
COIN
MARA
CLSK
RIOT
BTBT
MSTR
Cloning & Mutagenesis Research Report 2026 - Global Market Analysis, Competitive Landscape, Opportunities, and Forecasts, 2021-2025 & 2025-2031
globenewswire.com
TMO
CRSP
Global DNA Microarray Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~7% by 2034 | DelveInsight
globenewswire.com
CRSP
TMO
EDIT
LGL
SANG
PRGS
CELC
REGN
ILMN
MYGN
BIIB
DHR
ROST
QGEN
DGX
ABT
MRK
PACB
AZTA
CRISPR Therapeutics to Present at the Bank of America Securities 2026 Global Healthcare Conference
globenewswire.com
CRSP
Hemophilia Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
globenewswire.com
NVO
PFE
CSL
SNY
BMRN
ALNY
SANG
BE
REGN
NTLA
JNJ
ABBV
BMY
TEO
VRTX
CRSP
Form 8-K
sec.gov
CRSP
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results
globenewswire.com
CRSP
Converge Bio uses ConvergeAB to improve popular cancer treatment with a single prompt
prnewswire.com
CRSP
Global Metagenomics Sequencing Market to Register Stunning Growth at a CAGR of ~13% by 2034 | DelveInsight
globenewswire.com
CRSP
TMO
RGEN
ILMN
MYGN
DHR
QGEN
DGX
PACB
AMGN
AGNC
CELC
PERI
MRK
MTX
AZTA
Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsight
globenewswire.com
MRK
IPHA
VERU
KURA
INCY
AMGN
PFE
GILD
REGN
AZN
CRSP
BIIB
NTRA
ALLO
KYMR
ADCT
IMUX
CELC
ONON
ABBV
TDOC
BMY
IMVT
GNTX
IMPP
AUTL